Clinical Trials

Do Certain E. Coli Strains Increase Cancer Risk in Developed Countries?
Research & Development Do Certain E. Coli Strains Increase Cancer Risk in Developed Countries?

Scientists have long sought to understand the various factors that contribute to the prevalence of cancer, and recent research has shed light on a surprising potential culprit: Escherichia coli (E. coli). A study conducted by researchers from the Wellcome Sanger Institute and the University of

Is Clinical Research Advancing Inclusivity or Extracting Resources?
Research & Development Is Clinical Research Advancing Inclusivity or Extracting Resources?

Clinical research has long been a cornerstone of advancing medical science, characterized by a significant historical trajectory. Over decades, its momentum has increased with the advent of new knowledge and technologies, enabling the development of improved therapeutics. From the discoveries in

Aging Alters Iron Homeostasis, Reducing Lung Stem Cell Tumorigenesis
Research & Development Aging Alters Iron Homeostasis, Reducing Lung Stem Cell Tumorigenesis

Aging is a complex biological process that affects various cellular functions, including the behavior of stem cells. Recent research has shed light on how aging impacts iron homeostasis in lung stem cells, leading to a reduction in their tumorigenic potential. This article delves into the intricate

New Study Links Glyphosate to Neuroinflammation and Alzheimer's Risks
Research & Development New Study Links Glyphosate to Neuroinflammation and Alzheimer's Risks

The impact of glyphosate exposure on brain health has been a growing concern, and a new study has brought this issue to the forefront. The research highlights the potential link between the widely used herbicide and lasting brain inflammation, which could lead to neurodegenerative diseases such as

Alanis and KBI Partner to Advance Antibody Development for Blood Cancers
Biotech & Bioprocessing Alanis and KBI Partner to Advance Antibody Development for Blood Cancers

In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and acute

Is the HITS-Bio Technique Revolutionizing Tissue Engineering and Medicine?
Biotech & Bioprocessing Is the HITS-Bio Technique Revolutionizing Tissue Engineering and Medicine?

The field of tissue engineering and regenerative medicine has witnessed a groundbreaking advancement with the development of the High-throughput Integrated Tissue Fabrication System for Bioprinting (HITS-Bio) by researchers from Penn State. This innovative technology promises to transform the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later